Literature DB >> 10788630

Thrombin-induced inhibition of myoblast differentiation is mediated by Gbetagamma.

M Nagao1, Y Kaziro, H Itoh.   

Abstract

Thrombin has been shown to inhibit skeletal muscle differentiation. However, the mechanisms by which thrombin represses myogenesis remain unknown. Since the thrombin receptor couples to G(i), G(q/11) and G(12), we examined which subunits of heterotrimeric guanine nucleotide-binding regulatory proteins (Galpha(i), Galpha(q/11), Galpha(12) or Gbetagamma) participate in the thrombin-induced inhibition of C2C12 myoblast differentiation. Galpha(i2) and Galpha(11) had no inhibitory effect on the myogenic differentiation. Galpha(12) prevented only myoblast fusion, whereas Gbetagamma inhibited both the induction of skeletal muscle-specific markers and the myotube formation. In addition, the thrombin-induced reduction of creatine kinase activity was blocked by the C-terminal peptide of beta-adrenergic receptor kinase, which is known to sequester free Gbetagamma. These results suggest that the thrombin-induced inhibition of muscle differentiation is mainly mediated by Gbetagamma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788630     DOI: 10.1016/s0014-5793(00)01458-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

2.  Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering.

Authors:  Jun Liu; Hockin H K Xu; Hongzhi Zhou; Michael D Weir; Qianming Chen; Carroll Ann Trotman
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

3.  Thrombin causes the enrichment of rat brain primary cultures with ependymal cells via protease-activated receptor 1.

Authors:  Felix Tritschler; Radovan Murín; Barbara Birk; Jürgen Berger; Mirna Rapp; Bernd Hamprecht; Stephan Verleysdonk
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.